Transforming Eye Care With Precision Medicine
Character Bio is a precision medicine company unlocking the patterns of progressive polygenic diseases, with an initial focus on macular degeneration.
Age-related macular degeneration (AMD) impacts one in eight people over the age of fifty and is a leading cause of blindness globally.
Our mission is clear: Leverage human genetics to understand what drives disease progression so we can discover and develop targeted therapies to more effectively treat patients.
THE CHALLENGE
Addressing The Variability Of Polygenic Diseases
Patients who have polygenic diseases like AMD and Glaucoma exhibit different disease manifestations and progress at different rates due to their unique genetic and clinical profiles — but today’s therapies are blunt instruments that take a one-size-fits-all approach, failing to address underlying individual disease drivers.
At Character Bio, we’re leveraging proprietary world-class genomic databases to characterize these patient subtypes and discover genetic drivers of disease progression for more precise drug targeting.
Revolutionizing How Polygenic Eye Diseases Are Treated
Character Bio integrates genomics with longitudinal clinical data, imaging, and AI-enabled biomarker quantification for thousands of patients affected by AMD and POAG, leading us to unprecedented insights into the genetic drivers of disease progression.
This data platform is the foundation for Character Bio’s drug discovery and development pipeline.
This data platform is the foundation for Character Bio’s drug discovery and development pipeline.
Delivering The Promise Of Precision Medicine
By matching individual patients to specific medicines targeting key drivers of their disease, Character Bio can more effectively translate our work into therapies that reach the clinic.
Latest NEWS
News ·
March 25, 2025
Character Biosciences Raises $93 Million Series B
Funding will enable lead candidates for AMD to enter clinical trials in the next year
News ·
January 10, 2025
Character Bio Announces Collaboration with Bausch + Lomb
Collaboration seeks to transform ophthalmology with precision medicine
Partner With Us
Provider Partnerships
Partner with Character Bio on cutting-edge precision medicine research. Each collaboration is tailored to your practice flow to ensure seamless integration of research activities while providing ultimate benefits to your patients.
Patient Research Opportunities
As a patient, you have an opportunity to contribute to research that could deliver better treatments for you and others like you in the future.
Industry Partnerships
Work with us to harness the power of integrated patient data, genomics and machine learning to develop transformative medicines in ophthalmology.